Juvisé Pharmaceuticals
Global essential medicine provider
- B2B
- Has physical offices
- Manufacturing
- Sales-led purchase
About Juvisé Pharmaceuticals
Acquires princeps essential medicines, ensuring their production, marketing, and promotion to healthcare professionals globally for patients' health improvement.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Villeurbanne, Auvergne-Rhône-Alpes, France
- Founded
- 2008
- Revenue
- $18.2M – $143MTamtam estimate
- SIREN
- 509059879
- Website
- juvisepharmaceuticals.com
Jobs at Juvisé Pharmaceuticals
Juvisé Pharmaceuticals in the news
- Juvisé Pharmaceuticals : des médicaments essentiels, des responsabilités concrètes – L’interview d’Emilie Gounon
Juvisé Pharmaceuticals focuses on securing the supply chain for essential medicines while manufacturing 95% of its products within Europe.
- Juvisé Pharmaceuticals a entériné les nominations de Frédéric Mascha en tant qu’Executive Chairman et Président du comité de surveillance et de Renaud Sermondade en tant que nouveau CEO du groupe
Leadership changes at Juvisé Pharmaceuticals involve founder Frédéric Mascha moving to Executive Chairman and Renaud Sermondade taking over as CEO to drive M&A and global growth.
- White & Case advises Hayfin Capital Management on €550 million Juvisé Pharmaceuticals refinancing
Hayfin Capital Management provided €550 million in unitranche financing to Juvisé Pharmaceuticals for debt refinancing and acquisition capital.
- Juvisé Pharmaceuticals a entériné les nominations de Frédéric Mascha en tant qu’Executive Chairman et Président du comité de surveillance et de Renaud Sermondade en tant que nouveau CEO du groupe
Frédéric Mascha is transitioning to Executive Chairman and appointing Renaud Sermondade as the new CEO to lead growth and M&A strategies.
- Juvisé Pharmaceuticals Formally Approved the Appointments of Frédéric Mascha as Executive Chairman and Chairman of the Supervisory Committee and the Nomination of Renaud Sermondade as the Group’s New CEO
Juvisé Pharmaceuticals has restructured its top leadership with Frédéric Mascha becoming Executive Chairman and Renaud Sermondade joining as the new CEO to drive international M&A growth.
Juvisé Pharmaceuticals at a glance
Juvisé Pharmaceuticals is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Villeurbanne, Auvergne-Rhône-Alpes, France.
Juvisé Pharmaceuticals was founded in 2008.
Juvisé Pharmaceuticals has 51–250 employees.
Juvisé Pharmaceuticals's revenue is $18.2M – $143M (Tamtam estimate).
Juvisé Pharmaceuticals's SIREN number is 509059879.
Juvisé Pharmaceuticals is hiring: 1 recent open role, including Sales & Operations Planning Manager.
Selling to companies like Juvisé Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies